Health Data Analysis

Getting Your Health Data Actually Useful

Most people think Health Data Analysis starts when you open a tool like Python or R. It doesn't. It starts months earlier, in the form of messy claims data, inconsistent ICD codes, and lab results that don't line up because three different EHR systems each decided to store dates in different formats. I spent three weeks last year tracking down why our readmission predictions were spitting out impossible values. The culprit wasn't the model. It was a batch export where the timestamp column had been silently cast to integer instead of datetime, turning "2023-11-15 08:30:00" into something that looked like a random phone number. The model trusted it. The numbers just went sideways. The core of this work isn't fancy algorithms. It's figuring out what your data actually represents before you let anything near a prediction engine. Here's the practical breakdown of how I approach it, the tools I use, and where things routinely break. I use a conda environment with Python 3.10, pandas, numpy, sqlAlchemy, and psycopg2 for database work. For clinical data specifically, I add OHDSI's ATLAS vocabulary tools if I'm working with OMOP CDM data, and synthea if I need synthetic test data. The setup takes about twenty minutes on a clean machine. If you're pulling from a hospital data warehouse, you'll also need SSL certs and VPN access configured, which adds another hour of waiting for IT to approve requests. Factor that in before you start.

Key packages:

• pandas — data manipulation, handles most of the heavy lifting
• numpy — numerical operations, faster than native Python loops
• sqlalchemy — connects to Postgres, MySQL, and clinical data warehouses
• psycopg2 — direct PostgreSQL driver, better performance than generic SQLAlchemy
• scikit-learn — modeling when you need it
• plotly or matplotlib — visualization, plotly for interactive, matplotlib for publication

Extracting Clinical Data

Clinical data sits in weird places. You've got structured tables in your EHR with column names like "lab_result_numeric_value" and "lab_result_text_value," and unstructured notes in separate tables that you might not even have permission to query. The first step is understanding your schema. I always run a DESCRIBE or INFORMATION_SCHEMA query first to map out what's actually available, rather than assuming the documentation is current. For OMOP Common Data Model specifically, the person table is your entry point. Concept tables give you the vocabulary. The condition_occurrence, drug_exposure, and procedure_occurrence tables hold the actual clinical events. Lab results split across observation, measurement, and device_exposure depending on how your site mapped everything. I've seen sites put lab results in three different tables because they migrated from a different standards body and never cleaned it up. If you're working with raw HL7 or FHIR exports, the parsing is messier. FHIR resources are JSON, which is easier to work with than XML-based HL7 v2, but the consistency varies wildly by implementation. A FHIR observation resource for blood pressure might contain systolic and diastolic as separate entries, or as a single composite string, depending on the vendor. I wrote a small parser that normalizes these variations into a consistent DataFrame structure before doing any analysis. It runs in about five minutes on a year's worth of observations from a mid-sized hospital system.

Cleaning and Standardizing

This is where most projects stall. Clinical data has missing values that aren't missing at random. A lab result not showing up might mean the test wasn't ordered, or it might mean the result was normal and the system suppressed it. I treat every missingness pattern as a hypothesis to test, not a simple null to drop. For date-time standardization, I convert everything to UTC. Hospital systems love their local time, and daylight saving shifts will silently corrupt your time-series analysis if you're not careful. I use pandas.to_datetime with utc=True and a specified timezone, then convert to UTC explicitly. Never trust implicit conversion. For concept ID standardization in OMOP data, I map all drug and condition codes through the source-to-concept mapping table. The mapping isn't always clean. Some source codes map to multiple concept IDs because the same code means different things in different contexts. I flag ambiguous mappings and review them manually. Skipping this step means your analysis will conflate two different drugs that share a code in one system but represent distinct medications in another.

I once found a cohort definition that was including patients because they had a drug exposure record, but the record was actually a medication reconciliation entry, not an administered dose. The patient hadn't received the drug. They'd simply been prescribed it years earlier during an admission that ended months ago. My workaround was adding a visit_occurrence join with a date window, filtering exposures to fall within the actual admission period. That reduced our cohort size by forty percent and fixed the signal.

Exploratory Analysis

Before modeling, I run basic descriptive statistics and visualizations. I check the distribution of key variables, look for outliers, and examine correlations between clinical features. For time-series clinical data, I plot individual patient trajectories to spot patterns that aggregate statistics hide. A model trained on population averages can completely miss the fact that a particular biomarker spikes predictably only in the first forty-eight hours after admission. For survival analysis, which comes up constantly in Health Data Analysis work, I check the proportional hazards assumption before fitting any Cox models. I use the log-minus-log plot method. When it fails, which it often does with clinical data, I switch to stratified Cox models or Royston-Parmar flexible parametric survival models. These handle non-proportional hazards without requiring you to segment your time axis manually. One counter-intuitive thing I've learned: more features usually don't help clinical prediction models the way they help other ML tasks. Hospital data has high dimensionality but low sample size relative to that dimensionality. I typically keep the feature set under fifty variables for any model working with fewer than five thousand patients. Beyond that, regularization helps, but the model starts fitting noise in the covariates. I've seen people throw in every lab result available and then wonder why the AUC drops when they test externally. The external hospital has different lab reference ranges, different ordering practices, and the model is picking up on artifacts instead of signal.

Validation and Reporting

Split your data by time, not randomly. If you train on 2020-2022 and test on 2023, you're testing temporal generalizability, which matters for deployment. Random splitting within the same time window gives you optimistic estimates that collapse as soon as the model ships. I usually hold out the most recent quarter for testing. That's the realistic scenario: the model works on historical data and you want to know if it'll work next quarter. Report calibration, not just discrimination. A model with good AUC but poor calibration will systematically over-predict or under-predict risk, which is worse than a slightly less accurate but well-calibrated model in a clinical setting. I use calibration plots and the Brier score. The Hosmer-Lemeshow test is still commonly cited but I avoid it because it's overly sensitive to sample size and under-sensitive to clinically meaningful miscalibration. Document your data lineage. Who extracted it, when, through what interface, and what transformations were applied. This isn't bureaucracy. It's the difference between being able to reproduce a finding six months later and spending two weeks trying to remember why a column name changed in the middle of the pipeline.

Where This Breaks Down

Health Data Analysis fails in specific scenarios. Small patient populations, under five hundred cases for the outcome you're studying, make any model unstable. Rare disease work requires federated approaches across multiple sites because no single hospital has enough data. Another failure mode is when your data source has systematic reporting bias. Emergency department flow is recorded differently than inpatient flow. Outpatient clinic data is incomplete because follow-up visits get logged in a separate system. If your study population mixes these sources without accounting for the structural differences, your results will reflect the reporting artifact, not the clinical reality. There's no free lunch here. You need to understand the data generation process before you trust any output. The tools matter less than that understanding.